{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T09:10:30Z","timestamp":1795252230939,"version":"4.10.3"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:p>Type 1 diabetes mellitus is a lifelong condition. It requires intensive patient involvement including frequent glucose measurements and subcutaneous insulin dosing to provide optimal glycemic control to decrease short- and long-term complications of diabetes mellitus without causing hypoglycemia. Variations in insulin pharmacokinetics and responsiveness over time in addition to illness, stress, and a myriad of other factors make ideal glucose control a challenge. Control-to-range and control-to-target artificial pancreas devices (closed-loop artificial pancreas devices [C-APDs]) consist of a continuous glucose monitor, response algorithm, and insulin delivery device that work together to automate much of the glycemic management for an individual while continually adjusting insulin dosing toward a glycemic target. In this way, a C-APD can improve glycemic control and decrease the rate of hypoglycemia. The MiniMed 670G (Medtronic, Fridley, MN) system is currently the only Food and Drug Administration\u2013cleared C-APD in the United States. In this system, insulin delivery is continually adjusted to a glucose concentration, and the patient inputs meal-time information to modify insulin delivery as needed. Data thus far suggest improved glycemic control and decreased hypoglycemic events using the system, with decreased need for patient self-management. Thus, the anticipated use of these devices is likely to increase dramatically over time. There are limited case reports of safe intraoperative use of C-APDs, but the Food and Drug Administration has not cleared any device for such use. Nonetheless, C-APDs may offer an opportunity to improve patient safety and outcomes through enhanced intraoperative glycemic control. Anesthesiologists should become familiar with C-APD technology to help develop safe and effective protocols for their intraoperative use. We provide an overview of C-APDs and propose an introductory strategy for intraoperative study of these devices.<\/jats:p>","DOI":"10.1213\/ane.0000000000003779","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T08:51:26Z","timestamp":1536310286000},"page":"902-906","source":"Crossref","is-referenced-by-count":12,"title":["Perioperative Considerations for Evolving Artificial Pancreas Devices"],"prefix":"10.1213","volume":"128","author":[{"given":"Micah T.","family":"Long","sequence":"first","affiliation":[{"name":"Anesthesiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Coursin","sequence":"additional","affiliation":[{"name":"Anesthesiology"},{"name":"Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Rice","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/EDE.0b013e31829ef01a","article-title":"The prevalence of type 1 diabetes in the United States.","volume":"24","author":"Menke","year":"2013","journal-title":"Epidemiology"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"R3-20230721","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.2337\/db08-1084","article-title":"The barrier of hypoglycemia in diabetes.","volume":"57","author":"Cryer","year":"2008","journal-title":"Diabetes"},{"key":"R5-20230721","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2337\/dc15-2623","article-title":"Variability of insulin requirements over 12 weeks of closed-loop insulin delivery in adults with type 1 diabetes.","volume":"39","author":"Ruan","year":"2016","journal-title":"Diabetes Care"},{"key":"R8-20230721","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00125-016-4022-4","article-title":"Coming of age: the artificial pancreas for type 1 diabetes.","volume":"59","author":"Thabit","year":"2016","journal-title":"Diabetologia"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/dia.2016.0421","article-title":"Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes.","volume":"19","author":"Garg","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2337\/dc16-1094","article-title":"Home use of day-and-night hybrid closed-loop insulin delivery in suboptimally controlled adolescents with type 1 diabetes: a 3-week, free-living, randomized crossover trial.","volume":"39","author":"Tauschmann","year":"2016","journal-title":"Diabetes Care"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.3390\/s17010182","article-title":"Current and emerging technology for continuous glucose monitoring.","volume":"17","author":"Chen","year":"2017","journal-title":"Sensors (Basel)"},{"key":"R12-20230721","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.2337\/diabetes.52.11.2790","article-title":"Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor.","volume":"52","author":"Boyne","year":"2003","journal-title":"Diabetes"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1177\/193229680900300528","article-title":"Delays in minimally invasive continuous glucose monitoring devices: a review of current technology.","volume":"3","author":"Keenan","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/1932296815578716","article-title":"Rate-of-change dependence of the performance of two CGM systems during induced glucose swings.","volume":"9","author":"Pleus","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4065\/83.4.400","article-title":"Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index.","volume":"83","author":"Desachy","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1007\/s10439-016-1679-2","article-title":"A review of safety and design requirements of the artificial pancreas.","volume":"44","author":"Blauw","year":"2016","journal-title":"Ann Biomed Eng"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10877-017-0086-z","article-title":"Accuracy and reliability of a subcutaneous continuous glucose monitoring device in critically ill patients.","volume":"32","author":"Rijkenberg","year":"2018","journal-title":"J Clin Monit Comput"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1177\/1932296814541810","article-title":"Characterizing accuracy and precision of glucose sensors and meters.","volume":"8","author":"Rodbard","year":"2014","journal-title":"J Diabetes Sci Technol"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12020-012-9765-1","article-title":"Continuous glucose monitoring in type 1 diabetes.","volume":"43","author":"Mauras","year":"2013","journal-title":"Endocrine"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1177\/1932296814543661","article-title":"Fault detection and safety in closed-loop artificial pancreas systems.","volume":"8","author":"Bequette","year":"2014","journal-title":"J Diabetes Sci Technol"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/193229681000400127","article-title":"Amperometric glucose sensors: sources of error and potential benefit of redundancy.","volume":"4","author":"Castle","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"R22-20230721","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/1932296816678631","article-title":"Sensor life and overnight closed loop: a randomized clinical trial.","volume":"11","author":"Tauschmann","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"R23-20230721","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/CCM.0000000000002274","article-title":"Glucose measurement in the ICU: regulatory intersects reality.","volume":"45","author":"Rice","year":"2017","journal-title":"Crit Care Med"},{"key":"R24-20230721","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/193229680700100510","article-title":"Continuous glucose sensors: continuing questions about clinical accuracy.","volume":"1","author":"Clarke","year":"2007","journal-title":"J Diabetes Sci Technol"},{"key":"R25-20230721","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/1932296814539589","article-title":"The surveillance error grid.","volume":"8","author":"Klonoff","year":"2014","journal-title":"J Diabetes Sci Technol"},{"key":"R26-20230721","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/193229681300700404","article-title":"Performance evaluations of continuous glucose monitoring systems: precision absolute relative deviation is part of the assessment.","volume":"7","author":"Obermaier","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/ALN.0b013e318236abf6","article-title":"Continuous measurement of glucose: facts and challenges.","volume":"116","author":"Rice","year":"2012","journal-title":"Anesthesiology"},{"key":"R28-20230721","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1089\/dia.2017.0087","article-title":"Accuracy of a fourth-generation subcutaneous continuous glucose sensor.","volume":"19","author":"Christiansen","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"R29-20230721","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/dia.2015.0405","article-title":"Accuracy of continuous glucose monitoring in patients after total pancreatectomy with islet autotransplantation.","volume":"18","author":"Forlenza","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"e12998","DOI":"10.1111\/petr.12998","article-title":"Continuous glucose monitoring following pancreatectomy with islet autotransplantation in children.","volume":"21","author":"Elder","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R32-20230721","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.mayocp.2017.03.009","article-title":"Blood gas analyzer accuracy of glucose measurements.","volume":"92","author":"Liang","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"R33-20230721","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1089\/dia.2012.0008","article-title":"Real-time continuous glucose monitoring in an intensive care unit: better accuracy in patients with septic shock.","volume":"14","author":"Lorencio","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"R34-20230721","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s13054-014-0453-9","article-title":"Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial.","volume":"18","author":"Boom","year":"2014","journal-title":"Crit Care"},{"key":"R35-20230721","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/CCM.0000000000003157","article-title":"Near-continuous glucose monitoring makes glycemic control safer in ICU patients.","volume":"46","author":"Preiser","year":"2018","journal-title":"Crit Care Med"},{"key":"R36-20230721","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2337\/dc09-1352","article-title":"Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial.","volume":"33","author":"Holzinger","year":"2010","journal-title":"Diabetes Care"},{"key":"R37-20230721","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13054-017-1784-0","article-title":"Continuous glucose monitoring in the ICU: clinical considerations and consensus.","volume":"21","author":"Krinsley","year":"2017","journal-title":"Crit Care"},{"key":"R38-20230721","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.arcontrol.2012.09.007","article-title":"Challenges and recent progress in the development of a closed-loop artificial pancreas.","volume":"36","author":"Bequette","year":"2012","journal-title":"Annu Rev Control"},{"key":"R39-20230721","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1089\/dia.2013.0333","article-title":"Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes.","volume":"16","author":"Breton","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"R40-20230721","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/1932296815617968","article-title":"Artificial pancreas device systems for the closed-loop control of type 1 diabetes: what systems are in development?","volume":"10","author":"Trevitt","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"R42-20230721","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2152\/jmi.61.421","article-title":"Usefulness of artificial endocrine pancreas during resection of insulinoma.","volume":"61","author":"Hirose","year":"2014","journal-title":"J Med Invest"},{"key":"R43-20230721","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s10047-016-0925-6","article-title":"Strict blood glucose control by an artificial endocrine pancreas during hepatectomy may prevent postoperative acute kidney injury.","volume":"20","author":"Mita","year":"2017","journal-title":"J Artif Organs"},{"key":"R45-20230721","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1542\/peds.2006-0347","article-title":"Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery.","volume":"118","author":"Piper","year":"2006","journal-title":"Pediatrics"},{"key":"R46-20230721","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2337\/dc06-1602","article-title":"Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements.","volume":"30","author":"Weinstein","year":"2007","journal-title":"Diabetes Care"},{"key":"R47-20230721","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1932296817730375","article-title":"Investigation of pump compatibility of fast-acting insulin aspart in subjects with type 1 diabetes.","volume":"12","author":"Zijlstra","year":"2018","journal-title":"J Diabetes Sci Technol"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201905000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:32:44Z","timestamp":1786113164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201905000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000003779","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}